Anti-GPCR GPR18 antibody [EPR12359]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(4 Publications)
Rabbit Recombinant Monoclonal GPCR GPR18 antibody. Suitable for WB and reacts with Human samples. Cited in 4 publications.
View Alternative Names
GPCRW, GPR18, N-arachidonyl glycine receptor, NAGly receptor, G-protein coupled receptor 18
- WB
Supplier Data
Western blot - Anti-GPCR GPR18 antibody [EPR12359] (AB174835)
All lanes:
Western blot - Anti-GPCR GPR18 antibody [EPR12359] (ab174835) at 1/1000 dilution
Lane 1:
HuT-78 cell lysate at 10 µg
Lane 2:
293T cell lysate at 10 µg
Secondary
All lanes:
Goat anti-rabbit HRP at 1/2000 dilution
Predicted band size: 38 kDa
true
Related conjugates and formulations (1)
-
Anti-GPCR GPR18 antibody [EPR12359] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This receptor plays a role in cellular signaling as part of the cardiovascular and immune system regulation. GPR18 binds specific ligands such as N-arachidonoyl glycine facilitating intracellular communication and response to environmental changes. It does not function alone but integrates into GPCR complexes acting in concert with other receptors to regulate physiological functions like inflammation and cell migration.
Pathways
The involvement of GPR18 in the endocannabinoid signaling and in the immune system makes it an essential player. It interfaces significantly with the endocannabinoid system influencing pathways like the calcium signaling pathway and possibly the MAPK signaling pathway. GPR18 interacts with proteins such as CB2 (cannabinoid receptor 2) to modulate immune responses inflammation and other critical cellular processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in immunology 15:1458684 PubMed39380984
2024
Applications
Unspecified application
Species
Unspecified reactive species
Drug design, development and therapy 15:4687-4699 PubMed34815664
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 21: PubMed32075117
2020
Applications
Unspecified application
Species
Unspecified reactive species
Circulation 134:666-680 PubMed27507404
2016
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com